Besides presenting thorough validations of RoCK and ROI and the simultaneously-profiled transcriptome, we showcase multiple applications, including splice junction and alternative splicing detection in murine cells, as well as distinguishing between major and minor BCR::ABL1 fusion transcripts in two cell lines and a patient sample in the context of cancer. This evidence concerns the gene ABL1 and cancer.